Stay updated on Clinical Trial of IL-2 + Nivolumab in RCC
Sign up to get notified when there's something new on the Clinical Trial of IL-2 + Nivolumab in RCC page.

Latest updates to the Clinical Trial of IL-2 + Nivolumab in RCC page
- CheckyesterdayChange DetectedThe study record page now displays a generic error page instead of its content, rendering the record unavailable. Users cannot view the study details or related information until the error is resolved.SummaryDifference17%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA new page revision label, v3.6.4, was added in the page metadata and the previous label, v3.6.3, was removed.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check37 days agoChange DetectedPage revision updated from v3.6.2 to v3.6.3, signaling a new version of the page. This is a minor update to the page's content or layout and does not change the study data.SummaryDifference0.1%

- Check44 days agoChange DetectedThe page metadata revision label was updated to v3.6.2, replacing the previous v3.6.0.SummaryDifference0.1%

- Check58 days agoChange DetectedNo longer looking for participants was added, along with new help/join sections (How to Read a Study Record, Common Questions, How to Join a Study) and an Intervention/Treatment labeling update; the old Intervention / Treatment label was removed and the revision updated from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check65 days agoChange DetectedThe page revision label changed from v3.5.4 to v3.5.5, indicating a refreshed version of the page.SummaryDifference0.1%

Stay in the know with updates to Clinical Trial of IL-2 + Nivolumab in RCC
Enter your email address, and we'll notify you when there's something new on the Clinical Trial of IL-2 + Nivolumab in RCC page.